STAT

Can we get better at treating chronic illness? 3 ways to do it

We spoke to some experts in chronic disease and palliative care on ways to improve treatment in 2018 and beyond.

Roughly half of all adults in the U.S. have one or more chronic illnesses, with 25 percent suffering from two or more such conditions.

These people navigate a medical system of widely variable quality, an ever-shifting insurance landscape, and real-world considerations like broken cars, broken marriages, and bad jobs that can shape the patient journey as much as the latest medical discoveries.

Can we get any better at treating chronic illness, particularly when those illnesses become life-threatening? We spoke to some experts in the field on ways to make that happen in 2018 and beyond.

Steering precision

You're reading a preview, sign up to read more.

More from STAT

STAT4 min readSociety
Alzheimer’s Patients In Biogen Trial, Jolted By Revival Of Drug, Press For Access Once Again
When Biogen halted studies of its Alzheimer's drug, trial participants had been devastated. The revival of the drug on Tuesday was a jolt.
STAT4 min readLeadership & Mentoring
Opinion: New Leaders Needed To Translate Discoveries Into Patient Care
To facilitate new discoveries, today's and tomorrow's leaders need to understand and navigate the languages and cultures of multiple sectors, from health care systems and academia to industry, finance, and…
STAT2 min readScience
New Vertex Cystic Fibrosis Drug Approved, Extending Treatments To 90% Of Patients
Vertex Pharmaceuticals on Monday won approval for its fourth treatment for cystic fibrosis, a combination drug that extends a new form of therapy to 90% of CF patients. The drug will be marketed as Trikafta. The list price is $311,000 per year — the